Long-acting insulin

This page covers all Long-acting insulin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Insulin receptor.

Targets

Insulin receptor

Marketed (2)

• Once-daily Insulin · Hospital Universitario Dr. Jose E. Gonzalez · Diabetes
  Once-daily insulin replaces or supplements the body's natural insulin production to regulate blood glucose levels by facilitating glucose uptake into cells and promoting glycogen synthesis.
• Long acting insulin · Ain Shams University · Diabetes
  Long-acting insulin provides sustained glucose control by mimicking the body's basal insulin secretion over an extended period.

Phase 3 pipeline (1)

• Humulin L · Sanofi · Diabetes
  Humulin L is a long-acting insulin that binds to insulin receptors to facilitate glucose uptake and utilization in peripheral tissues.